Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Sufentanil for Analgesia in Post-Surgical ARDS
NCT06037330Phase 4Recruiting
- Start
- Sep 2023
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of nalbuphine in pain. Started Sep 2023; status: recruiting.
02
Drugs
nalbuphine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06037330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037330.